8-K current report · filed Oct 29, 2026

ResMed (RMD) 8-K Current Report: October 29, 2026

Item 2.02Item 8.01Item EX-99.1RMD overview

Short answer

ResMed (RMD) filed an 8-K current report with the SEC on October 29, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item 8.01 (Other Events), Item EX-99.1 (Exhibit EX-99.1). Exhibit 99.1 announces ResMed’s operating results for the quarter ended September 30, 2026.

ResMed 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Exhibit 99.1 announces ResMed’s operating results for the quarter ended September 30, 2026
  • Investors should review the accompanying release for revenue, earnings, margins, guidance and business drivers

Item 8.01 · Other Events

  • Quarterly cash dividend of $0.66 per share declared, signaling continued shareholder distributions
  • November 12, 2026 record date, with payment scheduled for December 17, 2026
  • November 11, 2026 ex-dividend date for NYSE shares and ASX-traded CDIs
  • CDI holders receive equivalent Australian-currency payment, reflecting the 10:1 CDI-to-share ratio

Item EX-99.1 · Exhibit EX-99.1

  • Q1 FY2027 revenue $1.415B, up 6%, with core constant-currency growth of 7% driven by sleep devices and masks
  • GAAP diluted EPS $2.92, up 23%; non-GAAP EPS $2.91, up 14%, supported by stronger gross margin
  • Non-GAAP gross margin expanded 50 basis points to 62.5%, while operating margin declined 30 basis points to 35.8%
  • MatrixCare divestiture closed, generating $450.8M proceeds and sharpening focus on sleep and breathing health
  • Shareholder returns exceeded $1.0B through repurchases and dividends, including a declared $0.66 quarterly dividend
  • FY2027 guidance unchanged: reported revenue $5.75B-$5.85B and non-GAAP EPS $12.00-$12.25

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other ResMed 8-K filings

Get the next RMD 8-K as it lands

Follow RMD for push alerts, or ask the research agent what this filing means.